未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials) (Nov, 10.1007/s10803-020-04709-8, 2020)
Crutel, Veronique; Lambert, Estelle; Penelaud, Pierre-Francois; Albarran Severo, Cristina; Fuentes, Joaquin; Rosier, Antoine; Hervas, Amaia; Marret, Stephane; Oliveira, Guiomar; Parellada, Mara; Kyaga, Simon; Gouttefangeas, Sylvie; Bertrand, Marianne; Ravel, Denis; Falissard, Bruno
分享
收藏
分享
收藏Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
Crutel, Veronique; Lambert, Estelle; Penelaud, Pierre-Francois; Severo, Cristina Albarran; Fuentes, Joaquin; Rosier, Antoine; Hervas, Amaia; Marret, Stephane; Oliveira, Guiomar; Parellada, Mara; Kyaga, Simon; Gouttefangeas, Sylvie; Bertrand, Marianne; Ravel, Denis; Falissard, Bruno
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏